TargaGenix

TargaGenix focuses on developing a novel nanoemulsion formulation for chemotherapy to enhance cancer treatment delivery and effectiveness while reducing side effects

Biotech & Life Sciences

Sector

Seed

Stage

Biotechnology

Model

01Company Overview

TargaGenix focuses on developing a novel nanoemulsion formulation for chemotherapy to enhance cancer treatment delivery and effectiveness while reducing side effects.

02Backed By1 investor

ACAJI Capital→

03Similar Companies